"/> Novus Biologicals™ Antigène protéique recombinant… | B-LABO France

Novus Biologicals™ Antigène protéique recombinant NME7

Réf. : BL-RE-051016Réf. fabricant : 18222702 100μL
242,97 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
29922
Méthode de purification
>80% by SDS-PAGE and Coomassie blue staining
Nom usuel
NME7 Recombinant Protein Antigen
Contenu et stockage
Store at −20°C. Avoid freeze-thaw cycles
Formule
PBS and 1M Urea, pH 7.4
Marque
Novus Biologicals

A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human NME7.

Points forts

Source

E.coli

Amino Acid Sequence

SIRALFGTDGIRNAAHGPDSFASAAREMELFFPSSGGCGPANTAKFTNCTCCIVKPHAVSEGLLGKILMAIRDAGFEISAMQMFNMDRVN The NME7 Recombinant Protein Antigen is derived from E. coli. The NME7 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-051016
Réf. fabricant18222702
Gene ID (Entrez)29922
Méthode de purification>80% by SDS-PAGE and Coomassie blue staining
Nom usuelNME7 Recombinant Protein Antigen
Contenu et stockageStore at −20°C. Avoid freeze-thaw cycles
FormulePBS and 1M Urea, pH 7.4
À utiliser avec (application)Blocking/Neutralizing, Control
Alias de gèneEC 2.7.4.6, FLJ37194, MN23H7, NDK 7, NDP kinase 7, nm23-H7, non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase), nucleoside diphosphate kinase 7, nucleoside-diphosphate kinase 7
Symbole de gène(s)NME7
Type d’étiquetteUnlabeled
Type de produitRecombinant Protein Antigen
Quantité100μL
État réglementaireRUO
SourceE.coli
Réactivité spécifiqueThis recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51907. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml
Une question, une configuration particulière ?
Contactez-nous pour un devis.